XT
NRXP icon

XTX Topco’s NRX Pharmaceuticals NRXP Stock Holding History

XTX Topco’s Portfolio NRXP Stock Details NRXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$75.8K Sell
18,545
-60,188
-76% -$199K ﹤0.01% 3610
2026
Q1 		$168K Buy
+78,733
New +$159K ﹤0.01% 2909
2024
Q2 		– Sell
-3,940
Closed -$18.6K – 2288
2024
Q1 		$18.6K Buy
+3,940
New +$18.2K ﹤0.01% 1618
2023
Q4 		– Sell
-1,181
Closed -$3.07K – 1945
2023
Q3 		$3.07K Buy
+1,181
New +$3.93K ﹤0.01% 1482

Other funds holding NRXP

BGI
B Group Inc Dallas, Texas $213M AUM 96.05% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

XTX Topco's NRXP Position: Q2 2026 in Review

XTX Topco reduced its NRX Pharmaceuticals (NRXP) stake by 76% in Q2 2026, selling an estimated $199K and leaving 18,545 shares worth $75.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3610.

XTX Topco first reported a position in NRXP in Q3 2023 and has held it in 4 quarters since. The position peaked at $168K in Q1 2026. 47 funds tracked by Wall St. Rank hold NRXP as of Q2 2026.

  • XTX Topco held 18,545 shares of NRX Pharmaceuticals worth $75.8K as of Q2 2026.
  • XTX Topco sold 60,188 NRX Pharmaceuticals shares in Q2 2026, an estimated $199K.
  • NRX Pharmaceuticals made up ﹤0.01% of XTX Topco's portfolio in Q2 2026, its #3610 holding.
  • XTX Topco first reported a position in NRX Pharmaceuticals in Q3 2023 and has held it in 4 quarters since.
  • XTX Topco's NRX Pharmaceuticals position peaked at $168K in Q1 2026.
  • 47 funds tracked by Wall St. Rank held NRX Pharmaceuticals as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.